Cargando…
Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we enrolled 17 CF patients for a study evaluating infla...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291286/ https://www.ncbi.nlm.nih.gov/pubmed/34295857 http://dx.doi.org/10.3389/fped.2021.645063 |
_version_ | 1783724607950290944 |
---|---|
author | Baresi, Giulia Giacomelli, Mauro Moratto, Daniele Chiarini, Marco Conforti, Immacolata Claudia Padoan, Rita Poli, Piercarlo Timpano, Silviana Caldarale, Francesca Badolato, Raffaele |
author_facet | Baresi, Giulia Giacomelli, Mauro Moratto, Daniele Chiarini, Marco Conforti, Immacolata Claudia Padoan, Rita Poli, Piercarlo Timpano, Silviana Caldarale, Francesca Badolato, Raffaele |
author_sort | Baresi, Giulia |
collection | PubMed |
description | Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we enrolled 17 CF patients for a study evaluating inflammatory markers. One of them developed COVID-19, giving us the possibility to analyze inflammatory markers in the acute phase as compared to levels detected before and after the infectious episode and to levels measured in the other CF patients enrolled to the study who did not experience COVID-19 and 23 patients referred to our center for SARS-CoV-2 infection. |
format | Online Article Text |
id | pubmed-8291286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82912862021-07-21 Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic Baresi, Giulia Giacomelli, Mauro Moratto, Daniele Chiarini, Marco Conforti, Immacolata Claudia Padoan, Rita Poli, Piercarlo Timpano, Silviana Caldarale, Francesca Badolato, Raffaele Front Pediatr Pediatrics Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, data registered in the European countries revealed increasing cases of infection in cystic fibrosis (CF) patients. In the course of this pandemic, we enrolled 17 CF patients for a study evaluating inflammatory markers. One of them developed COVID-19, giving us the possibility to analyze inflammatory markers in the acute phase as compared to levels detected before and after the infectious episode and to levels measured in the other CF patients enrolled to the study who did not experience COVID-19 and 23 patients referred to our center for SARS-CoV-2 infection. Frontiers Media S.A. 2021-07-06 /pmc/articles/PMC8291286/ /pubmed/34295857 http://dx.doi.org/10.3389/fped.2021.645063 Text en Copyright © 2021 Baresi, Giacomelli, Moratto, Chiarini, Conforti, Padoan, Poli, Timpano, Caldarale and Badolato. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Baresi, Giulia Giacomelli, Mauro Moratto, Daniele Chiarini, Marco Conforti, Immacolata Claudia Padoan, Rita Poli, Piercarlo Timpano, Silviana Caldarale, Francesca Badolato, Raffaele Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic |
title | Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic |
title_full | Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic |
title_fullStr | Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic |
title_full_unstemmed | Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic |
title_short | Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic |
title_sort | case report: analysis of inflammatory cytokines il-6, ccl2/mcp1, ccl5/rantes, cxcl9/mig, and cxcl10/ip10 in a cystic fibrosis patient cohort during the first wave of the covid-19 pandemic |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291286/ https://www.ncbi.nlm.nih.gov/pubmed/34295857 http://dx.doi.org/10.3389/fped.2021.645063 |
work_keys_str_mv | AT baresigiulia casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic AT giacomellimauro casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic AT morattodaniele casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic AT chiarinimarco casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic AT confortiimmacolataclaudia casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic AT padoanrita casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic AT polipiercarlo casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic AT timpanosilviana casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic AT caldaralefrancesca casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic AT badolatoraffaele casereportanalysisofinflammatorycytokinesil6ccl2mcp1ccl5rantescxcl9migandcxcl10ip10inacysticfibrosispatientcohortduringthefirstwaveofthecovid19pandemic |